2025-10-01 Steering Committee Meeting Notes

2025-10-01 Steering Committee Meeting Notes

Date

Oct 1, 2025

Attendees

(bolded names indicate attendance)

Stakeholder group

SHIELD organization

Name of SHIELD member

organization designation

Industry Entity

Labgnostic, Inc.

Steve Box

primary

 

 

alternate

Epic

Dan Rutz

primary

 

 

alternate

Biomerieux

Xavier Gansel

primary

 

 

alternate

Roche

Nick Decker - regrets

primary

Roche

Open

alternate

Healthcare Provider

Indiana University/Indiana University Health/Association for Molecular Pathology

Mehdi Nassiri, MD

primary

University of Wisconsin-Madison

Andrea Pitkus, PhD, MLS(ASCP)CM, FAMIA - regrets

primary

UT Southwestern Medical Center

Hung Luu

primary

UNMC

Scott Campbell - regrets

primary

Longtime Lab Professional

Carmen Pugh

primary

Sonic Healthcare

Eric Crugnale

primary

Former Quest Diagnostics

Collom, Craig D

primary

Patient Advocate

 OPEN

OPEN

individual

Standards Organization

SNOMED International

 

Jim Case

primary

Monica Harry

alternate

Regenstrief Institute

 

Marjorie Rallins

primary

Eza Hafeza - regrets

alternate

HL7

 

Julia Skapik

primary

 

alternate

Professional Organization

Association of Public Health Laboratories

 

Riki Merrick

primary

Christina Gallegos

alternate

Logica

 

Stan Huff

primary

 

alternate

CAP

 

Raj Dash - regrets

primary

 

alternate

AMP

 

Robyn Temple - regrets

primary

 

alternate

Governmental - non Voting

CMS

Michael Smalara

primary

Open

alternate

ASTP/ONC

Sara Armson

primary

 OPEN

alternate

CDC

Hubert Vesper (/DDNID/NCEH/DLS)

primary

Jasmine Chaitram

alternate

NLM

OPEN

primary

OPEN

alternate

FDA

 Keith Campbell

primary

Victoria Derbyshire

alternate

Guest

CAP

Kevin Schap

non-voting

Agenda and Notes

Item

Notes

Item

Notes

Quorum evaluation (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business)

Currently we have 17 named members (2 open slots), so 2/3 = 11 is quorum (excluding chair and government members).

# of voting member per charter: 13 - 21

# of non-voting members per charter: 7

 

Open Meeting

12:07 PM ET

Conferences/Webinars

  • SNOMED CT Business meeting need a few SHIELD introduction slides for Rob Hausam (unless anyone form SC attends and wants to do that) to present (since he is attending) as part of our feedback on container modeling in SNOMED CT for the eX-Health group in Europe - will be homework to review and eVote (possibly just use the one-pager for him to share and talk to)

  • AMIA November 15 - 19 in Atlanta, GA AMIA 2025 Annual Symposium Call for Participation was accepted

    • When will slides be available to review - @Julia Skapik?

    • Reviewing the updated SHIELD handout - @Eric Crugnale

  • ADLM webinar about SHIELD is scheduled for October 22, 2025 12 - 1 PM ET

    • Next Steps:

      • Share slides before or on Oct 14, 2025 call

    • ADVAMed Tech Conference

      • Nick being part of a Data standardization presentation / panel and likes to get permission to talk about Collaboartive Community work - you can always do that, just need to review/approve slides if formal presentation

SHIELD member survey results and road map review

 

Discussion:

SC could help set achievable deliverables with timelines - accepting good over perfect to keep with the timeline (make review of the deliverables topic

Prioritizing opportunities - do we comment on initiatives with short comment period, that interupt creation of planned deliverables

Do we want to make this special topic - for November?

and include highlighting the accomplishments we have had during the last year

Next calls

 

All SHIELD Calls

  • Sep 30, 2025

General Updates: 2024 - WG Chairs please make sure we have material for updates (at least notes we can link to)

Special Topic:

Nov 18, 2025

Steering Committee:

Oct 14, 2025 - SHIELD Topic #2 call to review the ADLM / AMIA? slides

Oct 15, 2025 - we will we also meet!

Adjourned

=> below not discussed

12:59 PM EDT

Membership

#1 Waiting for official NLM representative since John Snyders departure from NLM - Raja Cholan is still working on getting a new representatives, asked to keep informed on any feedback that is NLM related

#2 Announced the open Steering Committe slots on the ALL SHIELD call in July - so far no nominations - reach out to ADLM - who will do that?

Roadmap section updates in response to ONC comments on the SHIELD roadmap

Reviewing Updated Roadmap: https://aphlinformatics.atlassian.net/wiki/download/attachments/3214147628/DRAFT_UpdatedSHIELD_Community Roadmap_20250402.docx?api=v2

Changes are highlighted with markup addressing these ONC comments:

  1. Aligning the roadmap scope to the mission scope

  2. Addressing the concern that all standards need training and education

  • Still need to review this one: Reviewed 2Jul25 see page 5 added text.

  1. There are several solutions proposed, including repositories and tools, which need to be further evaluated before ONC could fully support the roadmap.  ONC suggests the roadmap be updated to include details around feasibility, scalability and how the proposed changes can be integrated into the current laboratory ecosystem (e.g., regulation and industry).

Identify components that could improve the ecosystem infrastructure, and then highlight the places where these components can be advanced / sustained or made easier to implement. Would SHIELD be willing to consider to provide an example implementation - create the structures and bound terminologies to showcase how each element would be properly represented be working.

(Action plan of which solutions would improve intereoperability. Why were these solutions chosen for the path forward. What is needed? How do you know this is the right path forward? Where’s the evidence this will work? )

For each of the Consideration sections we could certainly add a section on feasibility / requirements (e.g. continued funding for LIDR, better describing the intended use of ANY data element added, overall goal of LIDR, clearly delineate what is commonly used and is minimum, provide best practice and alternatives (non-preferred) - example would be metadata around the value sets in VSAC (curation / usage etc) to be able to ascertain quality) and highlight that other mechanisms are needed to achieve for adoption.

Discuss:

https://aphlinformatics.atlassian.net/wiki/spaces/SC/pages/2020966449

Have gotten some votes, Jim added comments and is requesting to slim down the White Paper - have sent it back to the LIDR WG

Standards WG Vocab Follow up

Continue LRI Review Summary Document

On prior calls we discussed #1, #2 and #15

Any answer about access to COSMOS data?

Collect quantitative result values from as many vendors we can - what would be the best way to get this? In 2018 (or was it 2020) several vendors had lists; would be good to get a list so we can make sure SCT codes are available for those - who has this action item?

Discuss:

Review Working Groups progress

THANK YOU to all the WG Chairs for their effort in moving SHIELD work forward!!!

Setting milestones for deliverables should be NEXT for WGs: they will be captured here: SHIELD WG Deliverables and Milestone Grid

Placeholder to get back to later

  • Request from e-XHealth project and HL7 Europe around remodeling the container hierarchy in SNOMED CT looking for input from laboratorians around some of the details

    • Update from Standards and Vocabulary WG

    • other topics around container:

      • model needs to allow for accommodating additives being added later vs being in applied by manufacturer

      • model needs to also allow for mapping to UDI (Medical device in USCDI) vs SNOMED CT

      • Timeline? They will be moving forward.

  • Electronic Health Records and Genomics AMP paper - do we need to do something with this as the Steering Committee?

  • Antimicrobial result reporting

    • Related work at HL7 Europe:

  • Electronic Health Records and Genomics

  • Other presentations to folks at FDA?

    • Data Standards Review Committee of the FDA – work with Helena Sviglin

    • FDA Scientific Computing Board (SCB)

    • Compass group lab

From Chat:

none

Action items

Quick decisions not requiring context or tracking

For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.

Decisions requiring context or tracking

For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.